2937.12.00.00/Insulin Lispro (Humalog)/Japan

Insulin Lispro (Humalog) from Japan

Rapid-acting insulin analogue created by recombinant DNA technology with amino acid modifications for faster absorption. Falls under HTS 2937.12.00.00 as a structural analogue of insulin used primarily as a hormone for glycemic control. Qualifies as a chain-modified polypeptide hormone per chapter notes.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Submit FDA IND/BLA documentation; verify analogue structure matches declared sequence

• Use validated refrigerated shipping with temperature data loggers; insulin analogues are heat-sensitive

• Avoid bulk packaging declarations; pure API form stays in 2937, finished injectables move to 3004

Insulin Lispro (Humalog) from Japan — Import Duty Rate | HTS 2937.12.00.00